Budamate Transhaler (budesonide/formoterol)
/ Lupin
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 02, 2024
NPPA Revises Ceiling Price Of FDC Budesonide Plus Formoterol Inhalation
(Medical Dialogues)
- "Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals has fixed and revised the ceiling price of the fixed-dose combination (FDC) the pulmonary drug Budesonide 400mcg plus Formoterol 6 mcg Inhalation (Dry powder inhalers) under the drugs (price control) order, 2013. The ceiling price of the fixed-dose combination (FDC) of the pulmonary drug Budesonide + Formoterol has been revised from Rs 6.62 to Rs 6.95."
Pricing • Chronic Obstructive Pulmonary Disease
June 17, 2021
Lupin gets CDSCO panel nod for phase III trial of Formoterol Fumarate, Budesonide FDC
(Medical Dialogues)
- "Pharmaceutical major, Lupin has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) for conducting phase III clinical trial of Fixed Dose Combination (FDC) of Formoterol Fumarate 12mcg and Budesonide 400mcg inhaler...The revised phase III protocol was made in line with the earlier SEC recommendation dated 03.12.2020...Lupin, was directed to revise and submit the phase III protocol of FDC of Formoterol Fumarate and Budesonide by clarifying the following points: Dose equivalency of DPI and MDI needs to be presented for the suitability..."
New P3 trial • Asthma • Respiratory Diseases
1 to 2
Of
2
Go to page
1